tyTreating hyperproliferative disorders including cancers by administering an oligonucleotide which shares at least 50% nucleotide sequence identity with the human telomere overhang repeat.US713838318 Oct 200421 Nov 2006Geron CorporationThat retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human t